ChemicalBook > Product Catalog >Pharmaceutical intermediates >Bulk Drug Intermediates >Alogliptin benzoate

Alogliptin benzoate

Alogliptin benzoate Suppliers list
Company Name: Jinan Ande Pharmaceutical Co.,Ltd.
Tel:
Email: andepharm@163.com
Products Intro: Product Name:Alogliptin benzoate
CAS:850649-62-6
Purity:99% Package:1KG;1USD
Company Name: Henan DaKen Chemical CO.,LTD.
Tel: +86-371-66670886
Email: info@dakenchem.com
Products Intro: Product Name:Alogliptin benzoate
CAS:850649-62-6
Purity:99.00% Package:100g,500g,1KG,10KG,100KG
Company Name: Henan Tianfu Chemical Co.,Ltd.
Tel: 0371-55170693
Email: info@tianfuchem.com
Products Intro: Product Name:Alogliptin benzoate
CAS:850649-62-6
Purity:0.99 Package:25KG,5KG;1KG;500G
Company Name: Hangzhou FandaChem Co.,Ltd.
Tel: 008615858145714
Email: fandachem@gmail.com
Products Intro: Product Name:Alogliptin Benzoate
CAS:850649-62-6
Purity:as in COA Package:as customers' requirements
Company Name: Nanjing ChemLin Chemical Industry Co., Ltd.
Tel: 025-83697070;product@chemlin.com.cn
Email: product@chemlin.com.cn
Products Intro: CAS:850649-62-6
Purity:98% Package:g-Kg Remarks:White to white powder

Lastest Price from Alogliptin benzoate manufacturers

  • Alogliptin benzoate
  • US $1.00 / KG
  • 2021-10-19
  • CAS:850649-62-6
  • Min. Order: 1KG
  • Purity: 99%
  • Supply Ability: 100
  • Alogliptin benzoate
  • US $10.00 / KG
  • 2021-09-26
  • CAS:850649-62-6
  • Min. Order: 1000KG
  • Purity: 99.99%
  • Supply Ability: 10000t
  • Alogliptin benzoate
  • US $10.00 / KG
  • 2021-09-07
  • CAS:850649-62-6
  • Min. Order: 1KG
  • Purity: 99%
  • Supply Ability: 20 tons
Alogliptin benzoate Basic information
Indications and Usage Mechanisms of Action Adverse reactions
Product Name:Alogliptin benzoate
Synonyms:(R)-2-((6-(3-aMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile benzoate;Alogliptin benzoate 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile benzoate;Alogliptin(Alogliptin benzoate;2-[6-[3(R)-AMinopiperidin-1-yl]-3-Methyl-2,4-dioxo-1,2,3,4-tetrahydropyriMidin-1-ylMethyl]benzonitrile benzoate Monobenzoate;Alogliptin API;ALOGLIPTIN(SYK-322) BENZOATE;(R)-2-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benz;2-[[6-[(3R)-3-aMino-1-piperidinyl]-3,4-dihydro-3-Methyl-2,4-dioxo-1(2H)-pyriMidinyl]Methyl]-Benzonitrile Monobenzoate
CAS:850649-62-6
MF:C25H27N5O4
MW:461.52
EINECS:691-730-4
Product Categories:antidiabetic;Inhibitors;Final material;pharmaceutical intermediate;API
Mol File:850649-62-6.mol
Alogliptin benzoate Structure
Alogliptin benzoate Chemical Properties
Safety Information
MSDS Information
Alogliptin benzoate Usage And Synthesis
Indications and UsageAlogliptin (benzoic acid) is a type-2 diabetes medication, and it is a type of serine protease dipeptidyl peptidase IV (DPP-4) inhibitor developed by the Japanese company Takeda. Alogliptin, used alone or in combination with other blood sugar-lowering medication, is usually well-tolerated in type-2 diabetes patients. This medication has a low risk of hypoglycemia, with Alogliptin treatment groups ≤8.3% and placebo groups ≤10.5%, and shows no difference between young and elderly patients. In addition to effectively lowering blood sugar, this medicine also lowers the risks of hypoglycemia and weight increase, overcoming great obstacles in patient treatment and providing new hope for diabetes treatment.
Mechanisms of ActionAlogliptin selectively inhibits DPP-4 to reduce the inactivation of glucagon-like peptide 1 (GLP-1) and increase the GLP-1 levels in the body, thus lowering blood sugar. Once blood sugar reaches normal levels, it will cease its sugar-lowering effects, thus effectively reducing the risks of hypoglycemia. Additionally, DPP-4 inhibitor also slows gastric emptying, increases the feeling of fullness, and controls appetite, thus helping patients control their weight.
Adverse reactionsCommon side effects of Alogliptin include nasopharyngitis, headaches, and upper respiratory tract infection. Most side effects are light to moderate and are unrelated to dosage.
UsesTreatment of type 2 diabetes.
DefinitionChEBI: A benzoate salt obtained by combining equimolar amounts of alogliptin and benzoic acid. Used for treatment of type 2 diabetes.
Clinical UseAlogliptin benzoate is a dipeptidyl peptidase IV (DPPIV) inhibitor discovered by Takeda Pharmaceuticals and approved in Japan in 2010 for the treatment of type II diabetes mellitus. Alogliptin is an oral drug for once a day dosing to complement diet and exercise. Alogliptin is the most selective marketed DPPIV inhibition and has similar PK and PD properties compared to previous entries. The discovery, structure-activity relationship of related analogs, and synthesis of this compound have been recently published.
Chemical SynthesisThe most convenient synthesis for scale-up will be highlighted from several published routes. Commercially available 2-cycanobenzyl amine 1 was reacted with methylisocyanate in DCM at ambient temperature to provide N-methyl urea 2 in 85% yield. Reaction of the urea 2 with dimethyl malonate in refluxing ethanol with sodium ethoxide as base gave the cyclized trione 3 in 78-85% yield. The trione 3 was then refluxed in neat POCl3 to provide the penultimate chloride crude 4 in 95% yield which was reacted with Boc-protected diamine 5 in the presense of potassium carbonate in DMF to furnish alogliptin I in 93-96% yield. Treatment of alogliptin with benzoic acid in ethanol at 60-70 °C followed by crystallization delivered the desired alogliptin benzoate (I).

Alogliptin benzoate Preparation Products And Raw materials
Tag:Alogliptin benzoate(850649-62-6) Related Product Information
Pidotimod AGOMELATINE Linagliptin Trelagliptin TAK-438 Trelagliptin succinate Teneligliptin tadalafi Lenalidomide Abiraterone acetate Rivaroxaban Azilsartan Vildagliptin Alogliptin benzoate Saxagliptin Benzoic acid Risperidone Alogliptin Impurity 16